semaglutide compounding news november 2025 Drug compounders sue FDA over declaration ending Wegovy shortage The weight loss drug shortage

The compound remains in Phase 3 clinical trials, with multiple studies expected to report results throughout this year

The term GLP-1 agonist refers to a type of medication that medical professionals may prescribe to patients needing treatment for high blood glucose levels or who may need assistance with managing their weight

Martinez is among roughly 22,000 people statewide who rely on Medicaid to cover anti-obesity drugs for weight loss alone, MassHealth reported

Instead, state boards of pharmacy regulate compounding practices

Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study